Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novatia is an analytical research and development company that provides specialized services to the pharmaceutical and biotechnology industries. Founded in 2002 by former Pharmacia scientists, the company focuses on high-end mass spectrometry (LC/MS) and nuclear magnetic resonance (NMR) analysis to support drug discovery and development. Novatia is widely recognized for its proprietary software solutions, most notably ProMass, which is an industry standard for the automated deconvolution of mass spectra for oligonucleotides and proteins. The company operates as a contract research organization (CRO), offering expertise in structural elucidation, impurity identification, and high-throughput screening. Their services cater to a broad range of modalities, including small molecules, peptides, and large biomolecules. Novatia is headquartered in Newtown, Pennsylvania, and serves a global client base of life science companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novatia.